Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
Dinali H. Fernando, Josephine M. Forbes, Peter Angus, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5037-5037
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
Wiramon Rungratanawanich, Ying Qu, Xin Wang, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 2, pp. 168-188
Open Access | Times Cited: 242
Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies
Mani Raj Chaudhary, Sakshi Chaudhary, Yogita Sharma, et al.
Biogerontology (2023) Vol. 24, Iss. 5, pp. 609-662
Closed Access | Times Cited: 72
Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk
Sebastian Brandhorst, Morgan E. Levine, Min Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation
Lulu Gao, Jia-Min Ma, Yanna Fan, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 1379-1392
Closed Access | Times Cited: 93
Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility
Katja C.W. van Dongen, Armand M.A. Linkens, Suzan Wetzels, et al.
Food Research International (2021) Vol. 147, pp. 110547-110547
Open Access | Times Cited: 65
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Luis A. Constantino‐Jonapa, Yoshua Espinoza-Palacios, Alma Reyna Escalona‐Montaño, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 431-431
Open Access | Times Cited: 38
The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism
Yifan Shu, Yujie Huang, Wei Dong, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125662-125662
Closed Access | Times Cited: 33
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study
Stephen A. Harrison, Vlad Ratziu, Jérémy Magnanensi, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 758-767
Open Access | Times Cited: 30
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Melissa Myint, Francesca Oppedisano, Valeria De Giorgi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Collagen crosslinking: effect on structure, mechanics and fibrosis progression
Wenyu Kong, Cheng Lyu, Hongen Liao, et al.
Biomedical Materials (2021) Vol. 16, Iss. 6, pp. 062005-062005
Closed Access | Times Cited: 44
Excessive gluconeogenesis causes the hepatic insulin resistance paradox and its sequelae
Arnold N. Onyango
Heliyon (2022) Vol. 8, Iss. 12, pp. e12294-e12294
Open Access | Times Cited: 31
Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
Pengyu Yao, Yajuan Liu
Molecules (2022) Vol. 28, Iss. 1, pp. 272-272
Open Access | Times Cited: 30
MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29
AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus
Yihui Gong, Zijun Liu, Yuanyuan Zhang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease
Haoxuan Zou, Xiaopu Ma, Fan Zhang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 18
AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review
Rimesh Pal, Sanjay Kumar Bhadada
Bone (2023) Vol. 176, pp. 116884-116884
Closed Access | Times Cited: 17
FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells
Evelyn A. Bates, Zachary A. Kipp, Wang‐Hsin Lee, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105691-105691
Open Access | Times Cited: 7
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Kavitha Sasidharan, Andrea Caddeo, Oveis Jamialahmadi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101352-101352
Open Access | Times Cited: 5
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Comparative Study of the Effects of Dietary-Free and -Bound Nε-Carboxymethyllysine on Gut Microbiota and Intestinal Barrier
Xiaojin Yuan, Juan Liu, Chenxi Nie, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 9, pp. 5014-5025
Closed Access | Times Cited: 5
Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model
Winston T Stauffer, Asha Z. Goodman, Michael Bobardt, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0298211-e0298211
Open Access | Times Cited: 5
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
Ohad Etzion, Avital Bareket‐Samish, David Yardeni, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 848-848
Open Access | Times Cited: 5
Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 6
Open Access | Times Cited: 5
An integrated zebrafish model and network pharmacology to investigate the mechanism of Chrysanthemum for treating metabolic dysfunction-associated fatty liver disease
Jingcheng Zhao, Jing Yang, Fei Yang, et al.
Food Chemistry (2025) Vol. 473, pp. 143134-143134
Closed Access
Long-Term Feasibility and Outcomes of a Digital Health Program to Improve Liver Fat and Cardiometabolic Markers in Individuals with Non-Alcoholic Fatty Liver Disease: A Prospective Single-Arm Feasibility Study (Preprint)
Sigríður Björnsdóttir, Hildigunnur Ulfsdottir, Elías F. Guðmundsson, et al.
(2025)
Closed Access
Page 1 - Next Page

Scroll to top